SSL completes sale of medical division with Silipos divestment

By Liz White, ERJ staff
London- SSL International plc is to sell its Silipos business, which marks the final phase of the UK group’s disposal of its medical division.

The group has exchanged conditional contracts to sell the Silipos unit for $15.5 million (Euro 12.6 million) to US-based Langer Inc. by the end of September.

Silipos makes gel-based products for prosthetic, orthopedic and skincare applications. The unit had sales in the year to 31 March 2004 of £12 million (Euro 17.6 million) and operating…

To read more,please login or register below.

Register
This is the first step to more free
content, user offers, subscriptions
and more.
Login
Log in here using the Email Address
and Password you signed up with